New responsive redesign elevates brand identity, reinforces key messaging and improves user experience
Monderer Design, a strategic branding and graphic design firm, has designed, developed and launched a responsive website for Sentien Biotechnologies. Sentien is developing innovative cell therapy applications to transform treatment of diseases caused by a dysregulated immune system. The new website is live at sentienbiotech.com
Monderer Design worked closely with the Sentien team to create a website that elevates brand identity, reinforces key messaging and improves user experience. A clean and fresh design that featured vibrant colors and scientific imagery strengthened the company’s brand and reinvigorated its web presence. Monderer Design also updated Sentien’s product, work space and leadership photography, and created a CEO video to showcase its innovative science, products and pipeline.
“As a clinical stage company preparing to raise our next round of financing, Sentien needed a website refresh to better reflect the promise of our science, the growing maturity of our clinical pipeline and our unique corporate culture,” said Brian Miller, Chief Executive Officer of Sentien. “Monderer Design came highly recommended and they did not disappoint. The team took the time to meet with us to thoroughly understand our needs and our vision. They were flexible, responsive and creative, and worked with us to meet a very tight deadline. We have already received a tremendous amount of positive feedback on the redesigned site and we look forward to continuing to work with the Monderer team in the future.”
Sentien Biotechnologies, Inc. is a privately-owned, clinical-stage company developing novel cell therapies that restore balance to the immune system and transform treatment options for patients with systemic inflammatory diseases. Our innovative blood conditioning approach has been proven to significantly enhance exposure and extend therapeutic activity of Mesenchymal Stromal Cells (MSCs). By immobilizing MSCs in an extracorporeal device, our flagship SBI-101 product enables sustained, controlled dosage of dynamically secreted anti-inflammatory and regenerative factors that are unattainable by direct injection or intravenous infusion.
About Monderer Design
Monderer Design builds vibrant, agile brands, providing expertise in identity design, corporate branding, collateral, website, event/conference, advertising and marketing program communications to visionary organizations. Our clients include: Cambridge Sound Management, Sigilon Therapeutics, Concentric, GreenLight Fund, BioAnalytix, Nuvera Fuel Cells, CanaccordGenuity, and MIT Sloan, and more. For more information, visit: www.monderer.com
